Identification of a rare MET variant in three siblings with extramammary Paget disease

Author:

Kobayashi Yuki12ORCID,Nakamura Yoshio2,Tahara Umi2,Nakamura Kohei3,Nakanishi Kuniaki4,Miyagawa Akihiro2,Horikawa Hiroto2,Kobayashi Kenta2,Funakoshi Takeru2,Sugano Kokichi567,Ushiama Mineko7,Yoshida Teruhiko7,Inazumi Toyoko1

Affiliation:

1. Department of Dermatology, Tachikawa Hospital, Federation of National Public Service Personnel Mutual Aid Associations , Tokyo , Japan

2. Department of Dermatology, Keio University School of Medicine , Tokyo , Japan

3. Genomics Unit, Keio Cancer Center, Keio University School of Medicine , Tokyo , Japan

4. Department of Pathology, Tachikawa Hospital, Federation of National Public Service Personnel Mutual Aid Associations , Tokyo , Japan

5. Center for Medical Genetics, Keio University School of Medicine , Tokyo , Japan

6. Department of Genetic Medicine, Sasaki Foundation, Kyoundo Hospital , Tokyo , Japan

7. Department of Genetic Medicine and Services, National Cancer Center Hospital , Tokyo , Japan

Abstract

Abstract Extramammary Paget disease (EMPD) is an intraepithelial adenocarcinoma that primarily affects the genital and axillary areas in older individuals. A limited number of paired patients with familial EMPD (i.e. parent–offspring, siblings) have been reported but the genetics have not yet been adequately studied. We report, to the best of our knowledge, the first familial cases of patients with EMPD involving three affected siblings. The tumour-only multigene panel testing using surgical specimens revealed a heterozygous c.2997A>C (p.Glu999Asp) nonsynonymous variant in the proto-oncogene MET (NM_000245.4) in the three affected siblings. The germline multigene panel testing using peripheral blood lymphocytes revealed the same missense MET variant in all five family members who were tested, including two asymptomatic offspring (51 and 37 years of age). The MET variant we identified could be involved in EMPD carcinogenesis. Further genomic analyses of patients with familial EMPD are warranted to validate the pathogenic relevance of MET variants in EMPD development.

Funder

JSPS KAKENHI

National Cancer Center Research and Development Fund

AMED

Publisher

Oxford University Press (OUP)

Reference10 articles.

1. Extramammary Paget’s disease: diagnosis, pathogenesis, and treatment with focus on recent developments;Ishizuki;Curr Oncol,2021

2. Genomic alterations as potential therapeutic targets in extramammary Paget’s disease of the vulva;Stasenko;JCO Precis Oncol,2020

3. Genetic analysis of mismatch repair genes alterations in extramammary Paget disease;Kang;Am J Surg Pathol,2016

4. A case report of familial extramammary Paget’s disease in female siblings;Rutnumnoi;Case Rep Dermatol,2021

5. Olaparib monotherapy for BRIP1-mutated high-grade serous endometrial cancer;Nakamura;JCO Precis Oncol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3